You are here
Media Advisory
Thursday, August 3, 2017
NIH Scientists Track Zika Virus Transmission in Mice
Study analyzes how virus is spread sexually and from mother to fetus.
What
National Institutes of Health scientists have developed a mouse model to study Zika virus transmitted sexually from males to females, as well as vertically from a pregnant female to her fetus. They are using the model to study how and when the virus is spread, including how the virus crosses the placenta, as well as to investigate potential treatments to block virus transmission.
Scientists from NIH’s National Institute of Allergy and Infectious Diseases (NIAID) developed the model, which was challenging because mice naturally defend against Zika virus better than people because they have a stronger interferon response. Interferon is a powerful antiviral protein that inhibits the virus. The researchers suppressed the interferon in specialized laboratory mice that also lack the ability to produce T cells or B cells. These mice, called anti-interferon Rag (AIR) mice, have prolonged virus infection in the testes, akin to Zika-infected men. This attribute allowed the investigators to study sexual transmission from male to female mice, which occurred frequently.
In addition to sexual transmission, the researchers also showed that Zika virus was transmitted vertically from pregnant AIR mice to their fetuses. The researchers found that only some fetuses from each female were infected with virus, suggesting that the placenta may be the most important barrier in preventing Zika virus from reaching the fetus. The group also found that the virus could be detected in fetal tissues other than mouse brain tissue, such as the lymph nodes. Studying how Zika virus is spread in mouse fetuses may help us understand how Zika infection leads to various birth defects in people.
Although Zika virus usually does not cause illness in people, the virus can cause birth defects when an infected pregnant woman transmits it to her fetus. While there are no licensed vaccines or treatments available for Zika virus, many candidates are in various stages of development.
Article
C Winkler et al. Sexual and Vertical Transmission of Zika Virus in anti-interferon receptor-treated Rag1-deficient mice. Scientific Reports. DOI: www.nature.com/articles/s41598-017-07099-7 (2017).
Who
NIAID Director Anthony S. Fauci, M.D., and Karin E. Peterson, Ph.D., a neuroimmunology investigator in NIAID’s Laboratory of Persistent Viral Diseases, are available to comment on this study.
Contact
To schedule interviews, please contact Ken Pekoc, (301) 402-1663, kpekoc@niaid.noh.gov.
NIAID conducts and supports research — at NIH, throughout the United States, and worldwide — to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH…Turning Discovery Into Health®